We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Physician-Assisted Suicide Program Wins Praise

By HospiMedica International staff writers
Posted on 23 Apr 2013
A new study reports that patients, their families, and their physicians are satisfied with a “death with dignity” physician-assisted suicide program made available to terminal cancer patients.

The program was instituted following legislation in 2008 in the US states of Washington and Oregon allowing physician-assisted suicide. More...
Patients must make two oral requests, with an interval of at least 15 days between, plus a written request in order to begin the process. Prescribing physicians as well as a different consulting physician must then confirm that the patient's disease is terminal and that the patient is competent and voluntarily requesting the prescription. An informed consent process is required, and when the prescription is being written, physicians must give the patient a chance to rescind.

The prescriptions must then be given directly to a pharmacist, who gives the lethal drug directly to the patient or an authorized agent. In all, 114 patients inquired about the program between March 5, 2009, and December 31, 2011. Of these, 44 (38.6%) did not pursue the program, and 30 (26.3%) initiated the process but either elected not to continue or died before completion. Forty participants went through the process of obtaining the prescription, but only 60% ultimately ingested it.

The most common reasons given by patients for participation in the program were loss of autonomy (97.2%), inability to engage in enjoyable activities (88.9%), and loss of dignity (75%). Eleven participants lived for more than six months after prescription receipt. Qualitatively, patients and families were grateful to receive the lethal prescription, whether it was used or not. The study describing the program and the results was published in the April 11, 2013, issue of the New England Journal of Medicine (NEJM).

“Our ‘Death with Dignity’ program both allows patients with cancer who wish to consider this option to do so within the context of their ongoing care and accommodates variation in clinicians' willingness to participate,” concluded lead author Elizabeth Trice Loggers, MD, PhD, and colleagues. “The program ensures that patients (and families) are aware of all the options for high-quality, end-of-life care, including palliative and hospice care, with the opportunity to have any concerns or fears addressed, while also meeting state requirements.”

The implementation of the “Death with Dignity” program was at undertaken at the Seattle Cancer Care Alliance (Washington, USA). For those patients who express interest in participating, a licensed social worker is assigned who acts as an advocate and performs an initial chart review and, if appropriate, links patients with physicians willing to write lethal prescriptions. The advocate helps the patients, family members, and physicians navigate the process and ensure compliance with the state's regulations. Staff and faculty physicians can opt out of participating in the program.

Related Links:

Seattle Cancer Care Alliance



Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hybrid Arch Device
Neo EDE
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.